Back to Journals » Lung Cancer: Targets and Therapy » Volume 5

Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence

Total article views   Abstract views HTML views PDF downloads Totals
4,751 Dovepress* 3,741 882+ 1,488 4,623
PubMed Central* 0 128 32 128
Totals 3,741 1,010 1,520 4,751
*Since 1 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar